174 related articles for article (PubMed ID: 34961825)
1. Clone Selection Artificial Intelligence Algorithm-Based Positron Emission Tomography-Computed Tomography Image Information Data Analysis for the Qualitative Diagnosis of Serous Cavity Effusion in Patients with Malignant Tumors.
Wei J; Li P; Zhang H; Zhu R
J Healthc Eng; 2021; 2021():4272411. PubMed ID: 34961825
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography-computed tomography (PET-CT) in suspected malignant pleural effusion. An updated systematic review and meta-analysis.
Fjaellegaard K; Koefod Petersen J; Reuter S; Malene Fischer B; Gerke O; Porcel JM; Frost Clementsen P; Laursen CB; Bhatnagar R; Bodtger U
Lung Cancer; 2021 Dec; 162():106-118. PubMed ID: 34775214
[TBL] [Abstract][Full Text] [Related]
3. A PET-CT score for discriminating malignant from benign pleural effusions.
Simó M; Persiva O; Sánchez L; Montoro B; Vázquez A; Sansano I; Alemán C
Med Clin (Barc); 2023 Nov; 161(10):422-428. PubMed ID: 37487808
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.
Yang MF; Tong ZH; Wang Z; Zhang YY; Xu LL; Wang XJ; Li W; Wu XZ; Wang W; Zhang YH; Jiang T; Shi HZ
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1457-1467. PubMed ID: 30903197
[TBL] [Abstract][Full Text] [Related]
5. The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.
Sun Y; Yu H; Ma J; Lu P
PLoS One; 2016; 11(8):e0161764. PubMed ID: 27560933
[TBL] [Abstract][Full Text] [Related]
6. [Clinical role of F-18 FDG PET/CT in differentiating malignant and benign pleural effusion in patients with lung cancer].
Liao R; Yang X; Wang S; Zhou Q; Nie Q; Zhong W; Dong S; Wu Y
Zhongguo Fei Ai Za Zhi; 2012 Nov; 15(11):652-5. PubMed ID: 23164351
[TBL] [Abstract][Full Text] [Related]
7. Differentiation between malignant and benign pleural effusion in patients with extra-pleural primary malignancies: assessment with positron emission tomography-computed tomography.
Toaff JS; Metser U; Gottfried M; Gur O; Deeb ME; Lievshitz G; Mercer D; Even-Sapir E
Invest Radiol; 2005 Apr; 40(4):204-9. PubMed ID: 15770138
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis between benign and malignant pleural effusion with dual-energy spectral CT.
Zhang X; Duan H; Yu Y; Ma C; Ren Z; Lei Y; He T; Zhang M
PLoS One; 2018; 13(4):e0193714. PubMed ID: 29641601
[TBL] [Abstract][Full Text] [Related]
9. CAMPO Precision128 Max ENERGY Spectrum CT Combined with Multiple Parameters to Evaluate the Benign and Malignant Pleural Effusion.
Zhang T; Wu C; Li Z; Ding Y; Wen L; Wang L
J Healthc Eng; 2021; 2021():5526977. PubMed ID: 33728032
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
Kim BS; Kim IJ; Kim SJ; Pak K; Kim K
Onkologie; 2011; 34(6):298-303. PubMed ID: 21625182
[TBL] [Abstract][Full Text] [Related]
11. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion.
Gupta NC; Rogers JS; Graeber GM; Gregory JL; Waheed U; Mullet D; Atkins M
Chest; 2002 Dec; 122(6):1918-24. PubMed ID: 12475827
[TBL] [Abstract][Full Text] [Related]
12. Reconstruction Algorithm-Based CT Imaging for the Diagnosis of Hepatic Ascites.
Zhang H; Lv W; Diao H; Shang L
Comput Math Methods Med; 2022; 2022():1809186. PubMed ID: 35572834
[TBL] [Abstract][Full Text] [Related]
13. Deep learning for diagnosis of malign pleural effusion on computed tomography images.
Ozcelik N; Ozcelik AE; Guner Zirih NM; Selimoglu I; Gumus A
Clinics (Sao Paulo); 2023; 78():100210. PubMed ID: 37149920
[TBL] [Abstract][Full Text] [Related]
14. [Value of PET/MRI in the diagnosis of malignant pleural effusion in comparison with PET/CT].
Peng WB; Sun X; Zhou M; Wei XS; Wu XZ; Ruan WW; Shi HZ; Lan XL; Zhou Q
Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(30):2363-2369. PubMed ID: 34404128
[No Abstract] [Full Text] [Related]
15. Indirect comparison of the diagnostic performance of
Hu X; Li D; Liang Z; Liao Y; Yang L; Wang R; Wang P; Cai J
BMC Cancer; 2021 Oct; 21(1):1080. PubMed ID: 34615498
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Differentiated Thyroid Cancer and Recurrent Laryngeal Nerve Function with 131 Iodine Based on Positron Emission Tomography/Computed Tomography Image Segmentation Algorithm.
Zhong Y; He J; Zhang C; Ardlee B
World Neurosurg; 2021 May; 149():428-435. PubMed ID: 33166689
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of malignant from benign pleural effusions based on artificial intelligence.
Wang S; Tan X; Li P; Fan Q; Xia H; Tian S; Pan F; Zhan N; Yu R; Zhang L; Duan Y; Xu J; Ma Y; Chen W; Li Y; Zhao Z; Liu C; Bao Q; Yang L; Jin Y
Thorax; 2023 Apr; 78(4):376-382. PubMed ID: 36180066
[TBL] [Abstract][Full Text] [Related]
18. Automated 3-dimensional elastic registration of whole-body PET and CT from separate or combined scanners.
Shekhar R; Walimbe V; Raja S; Zagrodsky V; Kanvinde M; Wu G; Bybel B
J Nucl Med; 2005 Sep; 46(9):1488-96. PubMed ID: 16157532
[TBL] [Abstract][Full Text] [Related]
19. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
Yildirim H; Metintas M; Entok E; Ak G; Ak I; Dundar E; Erginel S
J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
